Immunology Co. Unveils Platform And $60M In Investments
Ventus Therapeutics Inc. on Wednesday unveiled its immunology platform along with $60 million in early-stage financing from founding investor Versant Ventures and from GV, the venture capital arm of Google's parent...To view the full article, register now.
Already a subscriber? Click here to view full article